If there is a singular expanding space in medicine, it’s the rocket-speed development of new drugs, especially in light of COVID-19 research. Indeed, innovation in the pharmaceutical industry is there. Drug companies are motivated to improve upon what is and to research what could be in the near future. What is bottlenecking the progression is always the progression of clinical trials. Why clinical trials still lag while pharmaceutical science is running ahead could be as simple as a technology platform to help both keep the same pace. But are CROs ready for a unified technology platform to help each other make a COVID-19 collaboration happen?
The reports on clinical trial inefficiencies are depressing. If Big Pharma has so much money to burn, why aren’t they investing in better, faster clinical trials? Pharmaceutical companies farm out their clinical trials to CROs to do the research. Contracting companies to do your research for you is, of course, nothing new. Lots of other industries do it all the time. Trouble is, when you outsource, you have to understand that the contracting agency is going to deliver as inexpensively as possible in order to protect their profit margin. This leaves pharmaceutical companies in a bit of a bind when it comes to the speed of delivery, with little to no control over how it gets done.
Pharma Companies Need Better Insights With A UnifiedTechnology Platform For COVID-19 Research
Being able to see into a clinical trial midstream would be one of the best ways to gauge not only how a clinical trial is doing, but what needs to be changed to make COVID-19 research successful if something is not going as planned. Too often, reports on clinical trial successes and failures are looking at clinical trial data in the rearview mirror. This might be helpful for planning clinical trials in the future, but it certainly is not going to save a clinical trial now.
Big money is invested in getting a new drug to the clinical trial phase, shouldn’t that investment be protected as much as possible? Being able to peer into the clinical trial through a unified technology platform would be ideal for drug companies working on COVID-19 research to push the cure to market quickly. There is a lot riding on a new drug succeeding in the clinical trial phase for COVID-19. In fact, the whole world is anxiously waiting for it. Stock prices are weighted heavily against clinical trials in general. Seeing what is coming in the near future with COVID-19 research with accurate minute-by-minute data not only ensures the anticipated projections are on track but can prove its merit along the way. What pharmaceutical company wouldn’t want that?
CROs Will Need To Prepare To Change Their Workflow With New Technologies
One of the hesitations that always comes with something new is the cost of obtaining it and the decrease in productivity until the workforce fully adapts to the new technology. People don’t like change. Maybe they also don’t like being monitored the way a unified technology platform would be able to do for the pharmaceutical industry. Transparency is only good, depending on who you ask. Oversight into a clinical trial for a pharmaceutical company with a unified technology platform to provide that kind of COVID-19 research information is great. For the CRO, their clients being able to oversee with a lot of detail and pushback, make changes, and provide feedback in the middle of a clinical trial could be a stressful thing to adapt to.
Including all sides of clinical trials and coming together as one accord for the advancement of COVID-19 research as a whole would be the selling point all of them need. If the end goal really is providing mankind with the best kinds of treatments and therapies for COVID-19 available to us by science, then the idea of a unified technology platform is a no-brainer. So, are clinical trials ready for a unified technology platform to bring the pharmaceutical industry to the next level?
Communication Platforms Provide Data and User-Friendly Solutions For CROs
Communication is a major part of clinical trial success. It’s also a sticking point with patients and the reason why they may not see a clinical trial all the way through to completion. Much has to be done to get clinical trials up to the standard of communication that patients are used to seeing through their healthcare systems and care networks. A communication platform would be the most cost-effective and patient-centric solution for everyone. Most patients are using some kind of online communication tool already with their personal and professional networks. Using a unified technology platform to communicate with on the clinical trial side wouldn’t be such a big cavern to cross.
eCare Vault is the first solution of its kind to provide communication, workflow management, solid data aggregation, and user-friendliness into one platform to help with COVID-19 research. Patients like that they can access it 24x7 from any smart device and CROs and pharmaceutical companies love the real-time data and reporting it provides. Is your next clinical trial prepared for a unified technology platform? If you’d like to see how eCare Vault can take your clinical trials to the next level, contact us today for a free consultation.